Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001209191-24-001773

Options or other derivatives

  • Director acquired 40,950 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Behbahani Ali Director 2024-01-15 Grant or award · Option to purchase Ordinary Shares +40,950 40,950 D
Loading xslF345X05/doc4.xml…